Switch theme
Sign up to access all valuation multiples
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
2017
13.5K+
LTM Revenue $6.7B
LTM EBITDA $1.2B
$12.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Avantor has a last 12-month revenue (LTM) of $6.7B and a last 12-month EBITDA of $1.2B.
In the most recent fiscal year, Avantor achieved revenue of $6.8B and an EBITDA of $1.5B.
Avantor expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Avantor valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $6.7B | XXX | $6.8B | XXX | XXX | XXX |
| Gross Profit | $2.3B | XXX | $2.3B | XXX | XXX | XXX |
| Gross Margin | 34% | XXX | 34% | XXX | XXX | XXX |
| EBITDA | $1.2B | XXX | $1.5B | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 22% | XXX | XXX | XXX |
| EBIT | $1.1B | XXX | $638M | XXX | XXX | XXX |
| EBIT Margin | 16% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $688M | XXX | $712M | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $3.8B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Avantor's stock price is $13.
Avantor has current market cap of $8.8B, and EV of $12.6B.
See Avantor trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $12.6B | $8.8B | XXX | XXX | XXX | XXX | $1.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Avantor has market cap of $8.8B and EV of $12.6B.
Avantor's trades at 1.9x EV/Revenue multiple, and 8.5x EV/EBITDA.
Equity research analysts estimate Avantor's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Avantor has a P/E ratio of 12.8x.
See valuation multiples for Avantor and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $8.8B | XXX | $8.8B | XXX | XXX | XXX |
| EV (current) | $12.6B | XXX | $12.6B | XXX | XXX | XXX |
| EV/Revenue | 1.9x | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | 10.6x | XXX | 8.5x | XXX | XXX | XXX |
| EV/EBIT | 11.6x | XXX | 19.7x | XXX | XXX | XXX |
| EV/Gross Profit | 5.5x | XXX | n/a | XXX | XXX | XXX |
| P/E | 12.8x | XXX | 12.4x | XXX | XXX | XXX |
| EV/FCF | 17.3x | XXX | 18.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAvantor's last 12 month revenue growth is 0%
Avantor's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.
Avantor's rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Avantor's rule of X is 19% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Avantor and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 0% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 22% | XXX | XXX | XXX |
| EBITDA Growth | 2% | XXX | 4% | XXX | XXX | XXX |
| Rule of 40 | 16% | XXX | 22% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 19% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 24% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Sonic Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Bangkok Dusit Medical Services | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Avantor acquired XXX companies to date.
Last acquisition by Avantor was XXXXXXXX, XXXXX XXXXX XXXXXX . Avantor acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Avantor founded? | Avantor was founded in 2017. |
| Where is Avantor headquartered? | Avantor is headquartered in United States of America. |
| How many employees does Avantor have? | As of today, Avantor has 13.5K+ employees. |
| Who is the CEO of Avantor? | Avantor's CEO is Mr. Michael Stubblefield. |
| Is Avantor publicy listed? | Yes, Avantor is a public company listed on NYS. |
| What is the stock symbol of Avantor? | Avantor trades under AVTR ticker. |
| When did Avantor go public? | Avantor went public in 2019. |
| Who are competitors of Avantor? | Similar companies to Avantor include e.g. Australian Clinical Labs, Healius, Integral Diagnostics, Sonic Healthcare. |
| What is the current market cap of Avantor? | Avantor's current market cap is $8.8B |
| What is the current revenue of Avantor? | Avantor's last 12 months revenue is $6.7B. |
| What is the current revenue growth of Avantor? | Avantor revenue growth (NTM/LTM) is 0%. |
| What is the current EV/Revenue multiple of Avantor? | Current revenue multiple of Avantor is 1.9x. |
| Is Avantor profitable? | Yes, Avantor is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Avantor? | Avantor's last 12 months EBITDA is $1.2B. |
| What is Avantor's EBITDA margin? | Avantor's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of Avantor? | Current EBITDA multiple of Avantor is 10.6x. |
| What is the current FCF of Avantor? | Avantor's last 12 months FCF is $726M. |
| What is Avantor's FCF margin? | Avantor's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Avantor? | Current FCF multiple of Avantor is 17.3x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
